Ohio-based Minimally Invasive Devices lands an extra $2.5 million investment, capping a $11.5 million fundraising round.
Ohio-based Minimally Invasive Devices capped an $11.5 million Series B funding round with a final $2.5 million investment from Radius Ventures, according to a company statement.
MID said it's putting the new cash into marketing and sales for its FDA-cleared device for laparoscopic surgeons, the FloShield vision system.
Canaan Partners and Charter Life Sciences brought the company most of the way in the financing round, contributing $9 million to the Series B back in March.
The FloShield device is the 1st of its kind with features that help prevent camera obfuscation during laparoscopic surgery, according to the company. Modern video systems have little means of preventing fat, smoke or other contaminants from blocking the view while the camera's inside a patient, resulting in camera removal and cleaning up to 10 times an hour, MID said.
"FloShield has hit a bullseye in delivering on the number 1 need of all laparoscopic surgeons – that is, avoiding loss of vision due to debris and fogging of the lens, particularly during long, complex procedures," said Radius Ventures partner Jordan Davis in a prepared statement.
Edwards Lifesciences CEO Michael Mussallem says the company now expects the FDA to approve its next-...
Reva Medical begins enrolling patients in Europe for a trial of its Fantom bioresorbable stent.
A subcommittee of the U.S. Senate's powerful Finance Committee holds a hearing on the medical device...
Zimmer Holdings and Biomet find a buyer for the knee and elbow assets they pledged to divest to...